Bills: HB 1106, HB 3284, HB 541, HB 713, HB 1403, HB 1586, HB 1942, HB 2070, HB 2844, HB 2851, HB 3151, HB 3749, HB 3940, HB 3963, HB 4454, HB 4466, HB 4795, HB 5154, HB 5394, SB 1357, HB 1052, HB 4099, HB 4638, HB 5147

Keywords: child abuse, neglect, gender identity, sexual orientation, child welfare, marriage, family, Texas Commission, family welfare, marriage support, stability, premarital education, child development, strong families, direct patient care, healthcare, physicians, medical services, insurance regulation, maternal health

Bills: HB 1106, HB 3284, HB 541, HB 713, HB 1403, HB 1586, HB 1942, HB 2070, HB 2844, HB 2851, HB 3151, HB 3749, HB 3940, HB 3963, HB 4454, HB 4466, HB 4795, HB 5154, HB 5394, SB 1357, HB 1052, HB 4099, HB 4638, HB 5147

Keywords: child abuse, neglect, gender identity, sexual orientation, child welfare, marriage, family, Texas Commission, family welfare, marriage support, stability, premarital education, child development, strong families, direct patient care, healthcare, physicians, medical services, insurance regulation, maternal health

Transcript Highlights:

• But my next part of that would be what pharmaceutical coverage is...

Bills: HB1464, HB1635, HB2516, HB3317, HB3502, HB4012, HB4268, HB4386, HB4877, SB916

Keywords: prescription drugs, drug pricing, pharmacy benefits, health insurance, health benefit plan, insurer, HMO, self-insured employer, public employer, school district, county, municipality, university system, higher education, retirees, dependent coverage, stop-loss coverage, bulk purchasing, group purchasing, purchasing pool

Bills: SB6, SB7, SB8, SB11, SB12, SB13, SB15, SB 6, SB 7, SB 8, SB 11, SB 12, SB 13, SB 15, SB 17

Keywords: SB 6, Woman and Child Protection Act, abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, pro-life, pro-choice, Texas abortion law, civil liability, qui tam, private enforcement, bounty hunter law, attorney general, parens patriae, abortion litigation, anti-SLAPP, Texas Citizens Participation Act, fee shifting

Transcript Highlights:

• And we recognized that quite a while back and took action, where we now have the pharmaceutical companies

Bills: HB136, HB451, SB425, SB466, SB905, SB1986, SB2311, SB2450, SB2805, SB2826, SB2919, SB3001

Keywords: Medicaid, lactation, healthcare, consultation, reimbursement, maternal health, infant care, commercial sexual exploitation, child sex trafficking, human trafficking, child welfare, foster care, DFPS, Department of Family and Protective Services, juvenile probation, risk assessment, needs assessment, trauma screening, child abuse prevention, exploitation screening

Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.

Transcript Highlights:

• I would ask the pharmaceutical company, and I'd have them at my door the next day.
• something sinister happened during the COVID-19 pandemic, where the federal government and the pharmaceutical
• This is where the big pharmaceutical companies—I'm sorry, the big insurance companies—are making all

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Summary: The committee heard testimony on Senate Bill 883, which would protect physicians’ ability to prescribe off-label medications and treatments, framed by the author as a “Right to Treat” measure tied to COVID-19 care. Supporters, including physicians and patient-choice advocates, said the bill would safeguard the doctor-patient relationship and prevent interference by boards, pharmacies, or hospitals. Several witnesses described using hydroxychloroquine, ivermectin, budesonide, antibiotics, steroids, and monoclonal antibodies during the pandemic, and said they faced complaints, board scrutiny, or pharmacy refusals for those prescriptions. The bill was left pending after public testimony closed. The committee then took up Senate Bill 331, which would extend hospital price-transparency requirements to additional health care facilities such as freestanding ERs, urgent care and retail clinics, ambulatory surgical centers, outpatient clinics, and birthing centers. Proponents argued that broader disclosure of prices for shoppable services would help consumers compare costs and reduce surprise billing, while opponents from ambulatory surgery centers said the bill would impose costly compliance burdens on small providers and that insurers or the state already have much of the needed data. The bill was also left pending. Senate Bill 2422 would expunge Texas Medical Board records and impose reparations for disciplinary actions tied to COVID-era treatment decisions, including references to ivermectin, hydroxychloroquine, budesonide, and masks. The author and supporters argued that doctors were unfairly targeted for trying to save patients and should be made whole; the Texas Medical Board representative said most pandemic complaints were dismissed, that actions generally involved broader issues such as privileges, documentation, or informed consent, and that no physician was disciplined solely for prescribing off-label COVID medications. The bill was left pending. Finally, the committee heard Senate Bill 2207, which would loosen Texas Medical Board rules on physicians advertising themselves as board certified, especially by reducing barriers tied to maintenance of certification requirements. Supporters said the current rule is overly restrictive, inconsistent, and costly, and that it drives physicians out of practice; they also said Texas is one of only a few states with such a rule. Witnesses described hospitals using the rule against physicians and said the change would improve transparency and competition. The bill remained pending after testimony.

Bills: HCR1006, SB1226, SB1239, SB1309, SB2132, SB1189, SB1344, SB1295, SB1355, SB1998, SB1330, SB1297, SB1338, SB1546, SB1378, SB1859, SB1333, SB1341, SB1377, SB1990

Keywords: campaign finance, election spending, political spending, money in politics, constitutional amendment, Citizens United, free speech, ballot measures, elections, corruption, dark money, outside spending, foreign influence, special interests, corporations, unions, federalism, self-government, political equality, term limits

Transcript Highlights:

• We saw that quite a while back and took action where we now have the pharmaceutical companies cross-checking

Bills: HB136, HB451, SB425, SB466, SB905, SB1986, SB2311, SB2450, SB2805, SB2826, SB2919, SB3001, HB136

Keywords: Medicaid, lactation, healthcare, consultation, reimbursement, maternal health, infant care, commercial sexual exploitation, child sex trafficking, human trafficking, child welfare, foster care, DFPS, Department of Family and Protective Services, juvenile probation, risk assessment, needs assessment, trauma screening, child abuse prevention, exploitation screening

Transcript Highlights:

• I would ask the pharmaceutical company, and I'd have them at my door the next day.
• something... ...sinister happened during the COVID-19 pandemic, where the federal government and pharmaceutical

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Bills: HB178, HB124, HB96, HB250, SB289, SB317, HB359, HB178, HB124, HB96, HB250, SB289, SB317, HB359

Keywords: HB178, Ten Commandments, public schools, K-12 education, Alabama, school display, religious display, Bible, Judeo-Christian, Establishment Clause, church-state separation, religion in schools, founding documents, Mayflower Compact, Declaration of Independence, U.S. Constitution, Northwest Ordinance, social studies, civics, history curriculum

Bills: HB185, HB378, SB28, HB400, SB155, HB312, HB185, HB378, SB28, HB400, SB155, HB312

Keywords: appropriation, transportation, judicial system, funding, state budget, Pickens County, local act, vehicle tag fee, registration fee, issuance fee, motor vehicle registration, license plate, replacement tag, transfer tag, renewal fee, county revenue, earmarked funds, ambulance service, emergency medical services, EMS

Transcript Highlights:

• Members, last session I sponsored House Bill 1490, which created the Texas Pharmaceutical Initiative
• Members, the Texas Pharmaceutical Initiative is really an answer to trying to cut costs.

Bills: HB1106, HB3284, HB541, HB713, HB1403, HB1586, HB1942, HB2070, HB2844, HB2851, HB3151, HB3749, HB3940, HB3963, HB4454, HB4466, HB4795, HB5154, HB5394, SB1357, HB1052, HB4099, HB4638, HB5147

Keywords: child abuse, neglect, gender identity, sexual orientation, child welfare, marriage, family, Texas Commission, family welfare, marriage support, stability, premarital education, child development, strong families, direct patient care, healthcare, physicians, medical services, insurance regulation, maternal health

Transcript Highlights:

• that it gets tagged as a drug, but it's just another indication of the stranglehold that the pharmaceutical
• companies have on... ...the FDA and what's allowed out there because this is not something where the pharmaceutical

Bills: HB1106, HB3284, HB541, HB713, HB1403, HB1586, HB1942, HB2070, HB2844, HB2851, HB3151, HB3749, HB3940, HB3963, HB4454, HB4466, HB4795, HB5154, HB5394, SB1357, HB1052, HB4099, HB4638, HB5147

Keywords: child abuse, neglect, gender identity, sexual orientation, child welfare, marriage, family, Texas Commission, family welfare, marriage support, stability, premarital education, child development, strong families, direct patient care, healthcare, physicians, medical services, insurance regulation, maternal health

Bills: SB1117, SB1373, SB672, SB1986, SB1098, SB626, SB1784, SB2480, SB2487, SB437, SB660

Keywords: dentistry, botulinum toxin, aesthetic treatments, dental regulation, training, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges, SB 672, Texas hospital emergency operations plan, hospital diversion, emergency department, cyberattack, cyber security, power outage, electrical outage, patient diversion, hospital preparedness

Bills: SB1117, SB1373, SB672, SB1986, SB1098, SB626, SB1784, SB2480, SB2487, SB437, SB660

Keywords: dentistry, botulinum toxin, aesthetic treatments, dental regulation, training, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges, SB 672, Texas hospital emergency operations plan, hospital diversion, emergency department, cyberattack, cyber security, power outage, electrical outage, patient diversion, hospital preparedness

Transcript Highlights:

• started up around 7 or 8 years ago because they found it within the marketplace, especially in most pharmaceuticals

Bills: SB1423, SB1426, SB1502, SB1377, SB1983, SB1466, SB1645, SB1647, SB1847, SB1565, SB1562, SB1329, SB1383, SB1833, SB1555, SB1344

Keywords: Oklahoma Hospital Advisory Council, hospital licensure, public health, State Department of Health, State Board of Health, hospital regulations, healthcare regulation, hospital standards, hospital construction, hospital operations, stroke care, stroke system, emergency medical services, EMS transport, psychiatric treatment, chemical dependency treatment, substance use disorder, drug storage, pharmacy, quality indicators

Transcript Highlights:

• members, I appreciate the opportunity to lay out House Bill 4638. which relates to the Texas Pharmaceutical
• enough to remember when that changed, when you started to see some of these marriages between pharmaceutical
• So imagine for an indication that's not specifically indicated by the FDA, in this case a pharmaceutical

Bills: HB5141, HB4638, HB2264, HB2035, HB4813, HB4408, HB2684, HB1621, HB2300, HB216, HB3829, HB4466, HB1747, HB2284, HB3614, HB2587, HB3219, HB3318, HB5147, HB4014, HB216

Keywords: lease, state property, public purpose, Travis County, Health and Human Services, pharmaceutical initiative, drug distribution, healthcare services, generic drugs, advanced pharmaceuticals, cost savings, mental health, patient discharge, medical records, health care professionals, substance use, family involvement, chemical dependency, treatment facilities, minor admissions

Bills: SB191, HB84, HB79, SB132, HB108, HB109, HB110, HB114, HB118, HB120, HB122, HB124, HB126, HB128, HB129, HB131

Keywords: postpartum depression, mental health, Medicaid, screening, education, maternal health, Chiropractic, Board of Chiropractic Examiners, license renewal, continuing education, election procedures, off-label, pharmacists, medical treatment, state board of pharmacy, employment protection, SB132, Alabama, controlled substances, Schedule I

Transcript Highlights:

• , it's Looking at every pharmaceutical, in particular new pharmaceuticals, involves assessing the value
• And with pharmaceuticals, any kind of health care, but especially with pharmaceuticals, which are so
• It's their pharmacies and pharmaceuticals.
• Now it's pharmaceuticals.
• And that's a combination of using a lot of pharmaceuticals and very, very expensive pharmaceuticals.

Transcript Highlights:

• I agree that it's very clear that we need to focus on pharmaceutical manufacturers, pharmaceutical benefit
• That's far in excess of any pharmaceutical company, quite honestly.
• A new Office of Pharmaceutical Policy and Analysis was created within HPC.
• A new Office of Pharmaceutical Policy and Analysis was created within HPC.
• So basically the pharmaceutical companies don't have leverage against the PBMs? Yeah.

Keywords: 995, all

Summary: The Joint Committee on Health Care Financing held a public hearing on a broad set of health care bills focused on cost, market oversight, pharmaceutical access, transparency, hospital closures, and pharmacy access. Chairs John Lawn and Cindy Friedman opened by emphasizing recent health care reforms and the need for further action on the drug supply chain, PBMs, private equity, and affordability. The committee heard testimony on several measures, including a Betsy Lehman Center bill to make technical changes and create a permanent trust account for federal and private funding, and bills on hospital profits and fairness, hospital closures and health planning, pharmacy deserts, and health care market oversight and pharmaceutical access. No votes were taken during the hearing. On the hospital profits bill, physicians and labor advocates strongly supported capping hospital CEO compensation at 50 times the lowest-paid worker, requiring greater financial transparency, and directing penalties from high-margin public hospitals into a Medicaid reimbursement fund. Testifiers argued that executive pay is excessive while frontline staff and safety-net services are under strain. Committee members raised concerns about unintended consequences, including whether hospitals might shift workers to contract status or lose executive talent, and whether the bill would actually direct money to the safety net. Supporters responded that the measure is one piece of a larger effort and that the bill’s Medicaid reimbursement provisions would help underserved hospitals. Testimony on market oversight and pharmaceutical access centered on rising health care and drug costs, PBM practices, and the proposal to give the Health Policy Commission authority to set upper payment limits for certain drugs. Consumer advocates, disability advocates, an independent pharmacist, the Attorney General’s office, and others supported stronger oversight, citing premium increases, affordability problems, and the impact of high drug prices on patients and community pharmacies. Pharma and some industry witnesses opposed parts of the bill, warning that upper payment limits could disrupt access, create legal issues, and fail to address the broader supply chain. The committee also heard support for stronger hospital closure notice and public hearing requirements, and for a pharmacy deserts bill aimed at identifying and addressing closures like the one in Roxbury that affected thousands of patients.